US EditionIllumina widens access to cancer tests with Medicare and new CDx
Summary by Medical Device Network
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Illumina widens access to cancer tests with Medicare and new CDx
Illumina is expanding access to its oncology range of IVD tests, as its TruSight Oncology Comprehensive IVD is now covered under Medicare.The post Illumina widens access to cancer tests with Medicare and new CDx appeared first on Medical Device Network.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
